Remove 2019 Remove Data Entry Remove Pharmaceutical Companies
article thumbnail

Deviation investigation guidelines in the pharmaceutical industry

GMPSOP

The FDA issues numerous warning letters to companies yearly for violating regulatory expectations. In the five years between 2019 and 2023, the FDA issued the following warning letters, closely related to ineffective deviation investigation. Adulterated Pharmaceuticals: 396 warnings iii. incorrect data entry).